While gold (GCZ25) is usually seen as a defensive asset and investors don’t really expect it to keep outperforming risk ...

Lumentum Holdings delivered a strong Q4, beating revenue and EPS estimates, driven by robust cloud and AI demand. Click to ...

Growth stocks represent companies poised for rapid expansion, beating both the overall market and industry peers. This growth ...

Cellebrite (CLBT) boasts strong growth potential with robust financials, digital forensics leadership, and a durable moat.

He stated that there are a couple of factors behind this, including an improvement in trade, as more trade deals continue to ...

Toast shares dipped despite a strong Q2 showing and upped guidance. The company is seeing strong momentum in both its core ...

Three familiar dividend stocks are ideal choices for growth and income investors seeking reliable passive income with growth ...

These five large-cap value dividend stocks look poised to provide some second-half gains with steady ultra-high-yield ...

Newmont is generating strong earnings and record free cash flow amid climbing gold and silver prices. Investors should buy ...

Envista (NVST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

July 23, 2025 — 12:00 pm EDT Written by Zacks Equity Research for Zacks -> Doximity (DOCS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy).